305 related articles for article (PubMed ID: 17177966)
61. Primary Sjögren's syndrome.
Rischmueller M; Tieu J; Lester S
Best Pract Res Clin Rheumatol; 2016 Feb; 30(1):189-220. PubMed ID: 27421224
[TBL] [Abstract][Full Text] [Related]
62. Clinical and serologic study of Sjögren's syndrome in patients with progressive systemic sclerosis.
Osial TA; Whiteside TL; Buckingham RB; Singh G; Barnes EL; Pierce JM; Rodnan GP
Arthritis Rheum; 1983 Apr; 26(4):500-8. PubMed ID: 6838673
[TBL] [Abstract][Full Text] [Related]
63. Anti-salivary antibodies in primary Sjögren's syndrome.
Atkinson JC; Royce LS; Wellner R; Pillemer SR; Bermudez D; Fox PC
J Oral Pathol Med; 1995 May; 24(5):206-12. PubMed ID: 7616459
[TBL] [Abstract][Full Text] [Related]
64. Role of salivary IgA in the pathogenesis of Sjögren syndrome.
Berra A; Sterin-Borda L; Bacman S; Borda E
Clin Immunol; 2002 Jul; 104(1):49-57. PubMed ID: 12139947
[TBL] [Abstract][Full Text] [Related]
65. Autoantibodies in primary Sjögren's syndrome patients induce internalization of muscarinic type 3 receptors.
Jin M; Hwang SM; Davies AJ; Shin Y; Bae JS; Lee JH; Lee EB; Song YW; Park K
Biochim Biophys Acta; 2012 Feb; 1822(2):161-7. PubMed ID: 22137887
[TBL] [Abstract][Full Text] [Related]
66. Sjögren's syndrome--study of autoantigens and autoantibodies.
Routsias JG; Tzioufas AG
Clin Rev Allergy Immunol; 2007 Jun; 32(3):238-51. PubMed ID: 17992591
[TBL] [Abstract][Full Text] [Related]
67. A calreticulin-like protein co-purifies with a '60 kD' component of Ro/SSA, but is not recognized by antibodies in Sjögren's syndrome sera.
Lu J; Willis AC; Sim RB
Clin Exp Immunol; 1993 Dec; 94(3):429-34. PubMed ID: 8252803
[TBL] [Abstract][Full Text] [Related]
68. Sequential Use of Immunoblots for Characterization of Autoantibody Specificities.
Bartsch H; Bachmann MP
Methods Mol Biol; 2015; 1314():173-8. PubMed ID: 26139265
[TBL] [Abstract][Full Text] [Related]
69. Expression of Toll-Like Receptors in Peripheral Blood Mononuclear Cells of Patients with Primary Sjögren's Syndrome.
Karlsen M; Jakobsen K; Jonsson R; Hammenfors D; Hansen T; Appel S
Scand J Immunol; 2017 Mar; 85(3):220-226. PubMed ID: 27943374
[TBL] [Abstract][Full Text] [Related]
70. Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome.
Szabo K; Papp G; Barath S; Gyimesi E; Szanto A; Zeher M
Clin Immunol; 2013 May; 147(2):95-104. PubMed ID: 23578551
[TBL] [Abstract][Full Text] [Related]
71. Periductal lymphocytic infiltration of salivary glands in Sjögren's syndrome with relation to clinical and immunologic findings.
Saito T; Fukuda H; Arisue M; Matsuda A; Shindoh M; Amemiya A; Mizuno S
Oral Surg Oral Med Oral Pathol; 1991 Feb; 71(2):179-83. PubMed ID: 2003013
[TBL] [Abstract][Full Text] [Related]
72. Autoantigen-targeting microRNAs in Sjögren's syndrome.
Yang Y; Peng L; Ma W; Yi F; Zhang Z; Chen H; Guo Y; Wang L; Zhao LD; Zheng W; Li J; Zhang F; Du Q
Clin Rheumatol; 2016 Apr; 35(4):911-7. PubMed ID: 26888739
[TBL] [Abstract][Full Text] [Related]
73. IFI16 filament formation in salivary epithelial cells shapes the anti-IFI16 immune response in Sjögren's syndrome.
Antiochos B; Matyszewski M; Sohn J; Casciola-Rosen L; Rosen A
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232276
[TBL] [Abstract][Full Text] [Related]
74. Identification of specific autoantigens in Sjögren's syndrome by SEREX.
Uchida K; Akita Y; Matsuo K; Fujiwara S; Nakagawa A; Kazaoka Y; Hachiya H; Naganawa Y; Oh-Iwa I; Ohura K; Saga S; Kawai T; Matsumoto Y; Shimozato K; Kozaki K
Immunology; 2005 Sep; 116(1):53-63. PubMed ID: 16108817
[TBL] [Abstract][Full Text] [Related]
75. H1N1 vaccination in Sjögren's syndrome triggers polyclonal B cell activation and promotes autoantibody production.
Brauner S; Folkersen L; Kvarnström M; Meisgen S; Petersen S; Franzén-Malmros M; Mofors J; Brokstad KA; Klareskog L; Jonsson R; Westerberg LS; Trollmo C; Malmström V; Ambrosi A; Kuchroo VK; Nordmark G; Wahren-Herlenius M
Ann Rheum Dis; 2017 Oct; 76(10):1755-1763. PubMed ID: 28760805
[TBL] [Abstract][Full Text] [Related]
76. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome.
Haneji N; Nakamura T; Takio K; Yanagi K; Higashiyama H; Saito I; Noji S; Sugino H; Hayashi Y
Science; 1997 Apr; 276(5312):604-7. PubMed ID: 9110981
[TBL] [Abstract][Full Text] [Related]
77. STAT-5 is activated constitutively in T cells, B cells and monocytes from patients with primary Sjögren's syndrome.
Pertovaara M; Silvennoinen O; Isomäki P
Clin Exp Immunol; 2015 Jul; 181(1):29-38. PubMed ID: 25736842
[TBL] [Abstract][Full Text] [Related]
78. Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology.
Reksten TR; Jonsson MV
Oral Maxillofac Surg Clin North Am; 2014 Feb; 26(1):1-12. PubMed ID: 24287189
[TBL] [Abstract][Full Text] [Related]
79. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
[TBL] [Abstract][Full Text] [Related]
80. MHC class II molecules, cathepsins, and La/SSB proteins in lacrimal acinar cell endomembranes.
Yang T; Zeng H; Zhang J; Okamoto CT; Warren DW; Wood RL; Bachmann M; Mircheff AK
Am J Physiol; 1999 Nov; 277(5):C994-C1007. PubMed ID: 10564093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
